Wolfson, Rachel L.
Chantranupong, Lynne
Wyant, Gregory A.
Gu, Xin
Orozco, Jose M.
Shen, Kuang
Condon, Kendall J.
Petri, Sabrina
Kedir, Jibril
Scaria, Sonia M.
Abu-Remaileh, Monther
Frankel, Wayne N.
Sabatini, David M.
Article History
Received: 6 November 2016
Accepted: 25 January 2017
First Online: 15 February 2017
Competing interests
: D.M.S. is a founder, consultant and shareholder of Navitor Pharmaceuticals Inc., which is targeting the amino acid sensing pathway for therapeutic benefit. R.L.W., L.C. and J.M.O. are shareholders of Navitor Pharmaceuticals. R.L.W., L.C., J.M.O., D.M.S. and the Whitehead Institute have filed two provisional patents that relate to amino acid sensing by the mTOR pathway.